This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chumpitazi, B. F. F.
Right arrow Articles by Grillot, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chumpitazi, B. F. F.
Right arrow Articles by Grillot, R.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, January 2000, p. 438-443, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Aspergillus fumigatus Antigen Detection in Sera from Patients at Risk for Invasive Aspergillosis

Bernabé F. F. Chumpitazi,* Claudine Pinel, Bernadette Lebeau, Pierre Ambroise-Thomas, and Renee Grillot

Département de Parasitologie-Mycologie Médicale et Moléculaire, UPRES A, CNRS 5082, Hôpital Albert Michallon, 38043 Grenoble, France

Received 18 February 1999/Returned for modification 16 August 1999/Accepted 15 September 1999

We have developed an inhibition enzyme immunoassay (inhibition-EIA) to monitor for the occurrence of invasive aspergillosis (IA) in sera from 45 immunocompromised (IC) patients. The test uses rabbit polyclonal antibodies and a mixture of components from Aspergillus fumigatus, containing three predominant antigens with molecular weights of 18,000, 33,000, and 56,000. Circulating antigens were found in five of seven proven cases of IA due to A. fumigatus. In two of the five positive cases, antigenemia was detected with inhibition-EIA earlier than with X ray or other biological methods. No antigens were detected in the sera from two patients with proven IA due to Aspergillus flavus and Aspergillus terreus nor in the sera from four patients with probable IA. Circulating antigens were not detected in the control group, composed of 30 healthy adult blood donors. Four of the 32 at-risk patients examined, though they displayed no definite evidence of IA, gave a positive result in this test. The sensitivity, specificity, and positive predictive value of inhibition-EIA were 71.4, 94.4, and 71.2%, respectively. The data were compared with those obtained by a latex agglutination assay of galactomannan (GM) that was positive in only one patient with probable IA. The higher sensitivity obtained by inhibition-EIA may well be due to its ability to detect circulating antigens other than GM in the sera of IC patients with IA. Detecting these antigens may improve the diagnosis of IA, as they may serve as markers of this infection.

* Corresponding author. Mailing address: Département de Parasitologie-Mycologie, Hôpital Albert Michallon, BP 217, 38043 Grenoble cedex 9, France. Phone: (33) 4 76 63 71 01. Fax: (33) 4 76 51 86 67. E-mail: Bernabe.Chumpitazi{at}ujf-grenoble.fr.

Journal of Clinical Microbiology, January 2000, p. 438-443, Vol. 38, No. 1
0095-1137/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Hao, W., Pan, Y.-X., Ding, Y.-Q., Xiao, S., Yin, K., Wang, Y.-D., Qiu, L.-W., Zhang, Q.-L., Woo, P. C. Y., Lau, S. K. P., Yuen, K.-Y., Che, X.-Y. (2008). Well-Characterized Monoclonal Antibodies against Cell Wall Antigen of Aspergillus Species Improve Immunoassay Specificity and Sensitivity. CVI 15: 194-202 [Abstract] [Full Text]  
  • Serrano, M. C., Ramirez, M., Morilla, D., Valverde, A., Chavez, M., Espinel-Ingroff, A., Claro, R., Fernandez, A., Almeida, C., Martin-Mazuelos, E. (2004). A comparative study of the disc diffusion method with the broth microdilution and Etest methods for voriconazole susceptibility testing of Aspergillus spp.. J Antimicrob Chemother 53: 739-742 [Abstract] [Full Text]  
  • Gomez-Lopez, A., Garcia-Effron, G., Mellado, E., Monzon, A., Rodriguez-Tudela, J. L., Cuenca-Estrella, M. (2003). In Vitro Activities of Three Licensed Antifungal Agents against Spanish Clinical Isolates of Aspergillus spp.. Antimicrob. Agents Chemother. 47: 3085-3088 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Rezusta, A. (2002). E-Test Method for Testing Susceptibilities of Aspergillus spp. to the New Triazoles Voriconazole and Posaconazole and to Established Antifungal Agents: Comparison with NCCLS Broth Microdilution Method. J. Clin. Microbiol. 40: 2101-2107 [Abstract] [Full Text]  
  • Espinel-Ingroff, A., Bartlett, M., Chaturvedi, V., Ghannoum, M., Hazen, K. C., Pfaller, M. A., Rinaldi, M., Walsh, T. J. (2001). Optimal Susceptibility Testing Conditions for Detection of Azole Resistance in Aspergillus spp.: NCCLS Collaborative Evaluation. Antimicrob. Agents Chemother. 45: 1828-1835 [Abstract] [Full Text]  
  • Espinel-Ingroff, A. (2001). Comparison of the E-test with the NCCLS M38-P Method for Antifungal Susceptibility Testing of Common and Emerging Pathogenic Filamentous Fungi. J. Clin. Microbiol. 39: 1360-1367 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»